期刊
SCIENCE
卷 339, 期 6122, 页码 957-959出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1229259
关键词
-
资金
- NIH [T32 CA009172]
- Mittelman Family Fellowship
- National Institute of General Medical Sciences [T32GM07753]
- American Cancer Society
- NIH New Innovator Award [DP2OD002750]
- National Cancer Institute [R33CA126674]
- Novartis Institutes for Biomedical Research
- Melanoma Research Alliance
- Starr Cancer Consortium
Systematic sequencing of human cancer genomes has identified many recurrent mutations in the protein-coding regions of genes but rarely in gene regulatory regions. Here, we describe two independent mutations within the core promoter of telomerase reverse transcriptase (TERT), the gene coding for the catalytic subunit of telomerase, which collectively occur in 50 of 70 (71%) melanomas examined. These mutations generate de novo consensus binding motifs for E-twenty-six (ETS) transcription factors, and in reporter assays, the mutations increased transcriptional activity from the TERT promoter by two-to fourfold. Examination of 150 cancer cell lines derived from diverse tumor types revealed the same mutations in 24 cases (16%), with preliminary evidence of elevated frequency in bladder and hepatocellular cancer cells. Thus, somatic mutations in regulatory regions of the genome may represent an important tumorigenic mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据